Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-24 · accession 0001628280-23-009263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-27 | 2023-03-24 | MYGN | Haas Kevin Richard | CTO | F - Tax | $23.72 | -2,816 | 108.2K | -3% | -$66.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | F | D | 1,142 | $23.72 | 109,923 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-24 | F | D | 1,674 | $23.72 | 108,249 | D | — | — |